Top Companies to Build and Operate Mobile Clinics for Your Organization
Mobile clinics are expanding access to care by helping health care organizations deliver services directly to communities.
presented by
How A Small Rural Hospital Is Using AI to Catch Heart Disease Sooner
At Wayne General Hospital in rural Mississippi, clinicians are using Eko Health’s AI-powered digital stethoscope to detect heart conditions earlier in patients with limited access to specialists.
The New Blueprint: How Clever Care Health Plan is Scaling Its Member Experience [Video]
MedCity News was at the Vive conference and spoke with executives who shared their insights for the healthcare industry.
The Real Test for AI Diagnostics Isn’t Performance — It’s Clinical Adoption
Cardiology, in particular, offers a clear view into why so many AI solutions struggle to scale and what differentiates those that are poised for adoption.
Danaher Drops $10B to Snatch Masimo in Diagnostics Push
Danaher is acquiring Masimo in a $10 billion deal aimed at expanding its diagnostics portfolio and deepening its presence in acute care settings. The move reflects a broader industry shift toward consolidation and integrated care, as large healthcare companies seek scale and more continuous clinical data inside hospitals.
From Pandemic Urgency to Practical Impact: How Diagnostics Investment Priorities Are Evolving
Speed still matters, but there’s been a shift in the industry. It’s not enough to be scientifically sound. Now, practicality is of utmost importance.
Samsung’s New Ultrasound System Wants to Make Every Scan Consistent
Samsung launched a new ultrasound system at this year’s RSNA conference. The system, called the R20, is designed to reduce user variability through real-time guidance, as well as provide AI-powered diagnostic support.
How Artera is Using Agentic AI to Humanize Patient Care
Artera President Tom McIntyre talks about the practical application of AI in healthcare.
Eko Health’s AI for Cardiac Diagnoses Earns CMS Reimbursement Rate
This week, CMS established a reimbursement code for Eko Health’s AI platform, which seeks to aid clinicians in the diagnosis of heart conditions. The goal behind the technology is to help catch heart disease earlier, when it’s easier to treat, and to make high quality diagnostic care more accessible.
Alzheimer’s Disease Now Has Its First FDA-Cleared Blood Test
Fujirebio Diagnostics’ blood test for Alzheimer’s disease offers a less expensive and less invasive alternative compared to medical imaging and tests of cerebrospinal fluid. But competition looms from blood-based tests in development by other diagnostics companies.
Get a Snapshot of the Early Stage Life Science Startup Landscape
A webinar scheduled for Thursday May 8 at 1 pm ET sponsored by Mercury will explore how early-stage medtech and biopharma investors are looking at the market and how they're advising startups in the wake of cuts to NIH and SBIR grants.
What Do Early Stage Life Science Companies Need to Grow?
Scheduled for May 8 at 1 pm ET, the conversation will include Morgan Cheatham, head of healthcare and life sciences at Breyer Capital, Gurdane Bhutani, founder and managing partner of MBX Capital, and will be moderated by Mercury Head of Healthcare and Life Sciences Ben Kromnick.
The Mechanics of a More Connected Healthcare Ecosystem [Video]
Arbiter’s Anjali Jameson on hospital and payer alignment.
How Can Fintech Make it Easier for Early Stage Life Science Companies to Grow?
A webinar on May 8th will explore how a banking platform approach could be a resource for the needs of entrepreneurs across biotech, diagnostics, and other life science companies.
PCR Comes to the Home With FDA Authorization of Visby’s OTC Sexual Health Test
The FDA granted marketing authorization to a Visby Medical at-home PCR test for three common sexually transmitted infections. The Visby test yields results in about 30 minutes.
Labcorp Is Buying BioReference Health’s Cancer Testing Business for $192M
Labcorp’s latest acquisition brings the oncology testing business of BioReference Health. Opko Health, BioReference’s parent, has been cutting costs to return to profitability.
A Snapshot of Five Contenders to Combat Infectious Diseases in the Post-Pandemic Landscape
Infectious disease is the focus of the biopharma track at INVEST Pitch Perfect May 20-21 in Chicago. Register today!
Startup OncoSwab Aims to Make Lung Cancer Detection as Simple as Flu & Covid-19 Tests
Inspired by the speed and ease of at-home Covid-19 tests, OncoSwab is developing a test for lung cancer that detects signs of the disease from a nasal swab. The test could become an alternative to the medical imaging currently used to screen for lung cancer.